imiquimod has been researched along with Uterine Cervical Dysplasia in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 6 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vos Van Steenwijk, PJ; Hendriks, N; Hoosemans, L; Koeneman, MM; Kooreman, LFS; Kruitwagen, RFPM; Kruse, AJ; Nijman, HW; Penders, CGJ; Piek, JMJ; Sep, SJS; Slangen, BFM; van Beekhuizen, HJ; van de Sande, AJM; van Kuijk, SMJ | 1 |
| Bevilacqua, F; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, M; Erzeneoglu, E; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Kyrgiou, M; Madić, T; Planchamp, F; Preti, M; Regauer, S; Reich, O; Stockdale, C; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
| Costa, A; Freitas, G | 1 |
| Efthimiou, O; Furukawa, TA; Hamanishi, J; Horinouchi, N; Inayama, Y; Kawakami, K; Kosaka, K; Mandai, M; Mizuno, K; Murakami, R; Takamatsu, S; Taki, M; Yamaguchi, K; Yamanoi, K | 1 |
| Bauman, JE; Chow, HS; Desravines, N; House, M; Hsu, CH; Mohnot, S; O'Connor, S; Rahangdale, L; Sahasrabuddhe, V; Sauter, E | 1 |
| Accorsi, GS; Antoniazzi, M; Dos Reis, R; Fonseca, BO; Fregnani, JHTG; Matsushita, GM; Pantano, NP; Possati-Resende, JC; Salcedo, MP; Santana, IVV; Schmeler, KM | 1 |
| Laios, A; Lutchman-Singh, K; Mitsopoulos, V; Thomakos, N; Tranoulis, A | 1 |
| Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJM; van Kemenade, FJ | 1 |
| Dosekun, O; Farrugia, P; Lewis, F; Sethi, G | 1 |
| Chen, FP | 1 |
| de Witte, CJ; Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJ | 1 |
| Conway, K; Lewis, F; Sethi, G; Toby, M | 1 |
| Gerestein, KG; Koeneman, MM; Kruitwagen, RF; Kruse, AJ; van Beekhuizen, HJ; van de Laar, R; van de Sande, AJ | 1 |
| Gerestein, CG; Hopman, AHN; Koeneman, MM; Kooreman, LFS; Kruitwagen, RFPM; Kruse, AJ; Nijman, HW; Sep, SJS; Slangen, BFM; van Beekhuizen, HJ; van de Sande, M; Van Gorp, T; Zur Hausen, A | 1 |
| Barata, SA; Calhaz-Jorge, C; Colaço, AM; Lopes, JP; Policiano, AC | 1 |
| Gerestein, CG; Hopman, AH; Koeneman, MM; Kooreman, LF; Kruitwagen, RF; Kruse, AJ; Nijman, HW; Sep, SJ; Slangen, BF; van Beekhuizen, HJ; van de Sande, AJ; Van Gorp, T; Zur Hausen, A | 1 |
| Barton, DL; Clayton, AC; Gostout, BS; Jefferies, JA; Loprinzi, CL; McGovern, RM; Novotny, PJ; Pachman, DR; Sloan, JA | 1 |
| Kaushal, S; Kopparthy, P; Merideth, M; Pulanic, TK; Stratton, P | 1 |
| Grimm, C; Hefler, L; Heinze, G; Natter, C; Polterauer, S; Rahhal, J; Reinthaller, A; Speiser, P; Stary, G; Tempfer, CB | 1 |
| Benson, E | 1 |
| Baldauf, JJ; Baulon, E; Nisand, I; Rodriguez, B; Vautravers, A | 1 |
| Apgar, BS | 1 |
| Arany, I; Diaz-Arrastia, C; Dinh, TV; Gatalica, Z; Hannigan, E; Robazetti, SC; Tyring, SK | 1 |
6 review(s) available for imiquimod and Uterine Cervical Dysplasia
| Article | Year |
|---|---|
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus state
Topics: Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Papillomavirus Infections; Pregnancy; Quality of Life; Retrospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2023 |
Non-Excisional therapeutic modalities in vaginal intraepithelial neoplasia.
Topics: Carcinoma in Situ; Female; Humans; Imiquimod; Laser Therapy; Uterine Cervical Dysplasia; Vaginal Neoplasms | 2023 |
Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
Topics: Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Prospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2023 |
Efficacy of 5% imiquimod for the treatment of Vaginal intraepithelial neoplasia-A systematic review of the literature and a meta-analysis.
Topics: Administration, Intravaginal; Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Papillomavirus Infections; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Uterine Cervical Dysplasia; Vaginal Neoplasms; Young Adult | 2017 |
Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomavirus Infections; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2015 |
[Imiquimod and immune response modifiers in gynaecology].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Papillomavirus Infections; Treatment Outcome; Uterine Cervical Dysplasia | 2007 |
7 trial(s) available for imiquimod and Uterine Cervical Dysplasia
| Article | Year |
|---|---|
Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study.
Topics: Female; Humans; Imiquimod; Male; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2022 |
Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Combined Modality Therapy; Electrosurgery; Female; Humans; Imiquimod; Intention to Treat Analysis; Margins of Excision; Middle Aged; Neoplasm Grading; Papillomavirus Infections; Squamous Intraepithelial Lesions of the Cervix; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2021 |
TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
Topics: Adult; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Research Design; Single-Blind Method; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2018 |
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Neoplasm Grading; Pancreatitis-Associated Proteins; Quality of Life; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2016 |
Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents, Immunological; Female; Humans; Imiquimod; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2017 |
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Condylomata Acuminata; Drug Administration Routes; Female; Humans; Imiquimod; Papillomavirus Infections; Severity of Illness Index; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2012 |
Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Papillomavirus Infections; Remission Induction; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Viral Load; Young Adult | 2012 |
11 other study(ies) available for imiquimod and Uterine Cervical Dysplasia
| Article | Year |
|---|---|
Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Topics: Adult; Feasibility Studies; Female; Fluorouracil; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Prospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2023 |
Vulval disease in HIV-positive women attending a tertiary vulval dermatology clinic over a five-year period.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Imiquimod; Middle Aged; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Diseases | 2013 |
Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
Topics: Aminoquinolines; Antineoplastic Agents; Cervix Uteri; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Papanicolaou Test; Papillomavirus Infections; Retrospective Studies; Severity of Illness Index; Time Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vagina; Vaginal Neoplasms; Vaginal Smears | 2013 |
Usual vulval intraepithelial neoplasia in HIV-positive women - a case series.
Topics: Adult; Aged; Aminoquinolines; Anti-HIV Agents; Antineoplastic Agents; CD4 Lymphocyte Count; Female; HIV Seropositivity; Humans; Imiquimod; Middle Aged; Retrospective Studies; Treatment Outcome; Uterine Cervical Dysplasia; Vulvar Neoplasms | 2016 |
Physicians' Awareness, Attitudes, and Experiences Regarding Imiquimod Treatment of Vaginal and Cervical Intraepithelial Neoplasia.
Topics: Aminoquinolines; Antineoplastic Agents; Attitude of Health Personnel; Female; Humans; Imiquimod; Netherlands; Physicians; Professional Competence; Surveys and Questionnaires; Uterine Cervical Dysplasia; Vaginal Neoplasms | 2016 |
Topical Therapy With Imiquimod for Vaginal Intraepithelial Neoplasia: A Case Series.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vagina | 2016 |
Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2012 |
[Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Cryotherapy; Female; Gammapapillomavirus; Humans; Imiquimod; Immunocompromised Host; Laser Therapy; Lasers, Gas; Male; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Risk; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Warts | 2012 |
Imiquimod: potential risk of an immunostimulant.
Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Drug Antagonism; Female; Humans; Imiquimod; Immunosuppressive Agents; Papillomaviridae; Papillomavirus Infections; Recurrence; Skin Diseases; Spondylitis; Uterine Cervical Dysplasia; Vulvar Diseases; Warts | 2004 |
Changes in strategies for human papillomavirus genital disease.
Topics: Aminoquinolines; Colposcopy; DNA, Viral; Female; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Papillomaviridae; Papillomavirus Infections; Risk Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1997 |
Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
Topics: 2',5'-Oligoadenylate Synthetase; Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genital Neoplasms, Female; Humans; Imiquimod; Middle Aged; Ointments; RNA, Neoplasm; Time Factors; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2001 |